Overview
CEO of Vivid Dx (Oxford Science Park, Oxford University spin-out), appointed in January, 25 years of experience in medical innovation; the company uses AI + Raman spectroscopy to identify infectious pathogens within minutes, and has won USD 15 million seed from Oxford Science Enterprises and others (Source: vivid-dx.com official website leadership, PR Newswire 2026-07) (2026, 30, 7).
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
Vivid Dx（牛津科学园，牛津大学spin-out）CEO，2026年7月任命，25年医疗创新经验；公司用AI+拉曼光谱30分钟内识别感染病原体，获Oxford Science Enterprises等1500万美元seed（来源：vivid-dx.com官网leadership、PR Newswire 2026-07）。